drugset / Trial / NCT06697886

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

NCT06697886 ↗

Phase 3 Recruiting 480 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)

Timeline

Start
2023-11-16
Primary completion
2025-06-25
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Antiwei Granules Unknown 6 g Oral

Indications